Related Experiment Video
Updated: Aug 7, 2026
09:34
Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
Published on: November 27, 2017
On the way to reprogramming cells to pluripotency using cell-free extracts
Philippe Collas1, Christel K Taranger, Andrew C Boquest
1Institute of Basic Medical Sciences, Department of Biochemistry, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, Norway. philippe.collas@medisin.uio.no
Reproductive Biomedicine Online
|June 24, 2006
Summary
Researchers are exploring new ways to reprogram specialized cells into pluripotent stem cells for regenerative medicine. Alternative methods to somatic cell nuclear transfer, like cell fusion and extracts from pluripotent cells, are being developed to overcome technical and ethical barriers.
Area of Science:
- Cell biology
- Stem cell research
- Regenerative medicine
Background:
- Reprogramming differentiated cells to pluripotency holds promise for regenerative medicine.
- Somatic cell nuclear transfer faces technical and ethical limitations, hindering its application.
- Alternative strategies are crucial for advancing cell fate alteration technologies.
Purpose of the Study:
- To discuss recent non-nuclear transfer-based approaches for somatic cell reprogramming.
- To explore methods for enhancing the differentiation potential of reprogrammed cells.
- To present alternatives to somatic cell nuclear transfer for cell fate alteration.
Main Methods:
- Review of recent literature on non-nuclear transfer-based reprogramming techniques.
- Discussion of cell fusion between differentiated cells and embryonic stem cells.
- Analysis of the use of extracts from pluripotent cells for reprogramming.
Main Results:
- Non-nuclear transfer methods offer viable alternatives for cell reprogramming.
- Cell fusion and pluripotent cell extracts demonstrate potential in reprogramming somatic cells.
- These methods aim to generate multipotent or pluripotent cells from differentiated ones.
Conclusions:
- Alternative reprogramming strategies are essential due to limitations of somatic cell nuclear transfer.
- Cell fusion and extract-based reprogramming are promising avenues for regenerative medicine.
- Further research is needed to optimize these methods for clinical applications.
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...